查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
無標籤陣列系統市場 - 全球行業規模、佔有率、趨勢、競爭、機遇和預測，2018-2028 年。按類型、按應用、最終用戶、地區和競爭細分
市場調查報告書
商品編碼
1326506

無標籤陣列系統市場 - 全球行業規模、佔有率、趨勢、競爭、機遇和預測，2018-2028 年。按類型、按應用、最終用戶、地區和競爭細分

Label-free Array Systems Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Type, By Application, By End user, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計在 2024 年至 2028 年的預測期內，無標籤陣列系統市場將以令人印象深刻的年複合成長率成長。這可歸因於對個性化藥物、快速藥物輸送、生物標記識別、特定疾病或病症中特定蛋白質標誌物的識別以及無標籤陣列系統市場作為藥物發現研究工具的使用增加等因素的不斷成長的需求。

對個性化醫療的需求不斷增加

近年來，現代醫學逐漸走向精準醫學，以消除個體劑量的遺棄。無標記陣列系統消除了對染料、試劑、修飾細胞和標籤的需求，同時提供對活細胞實驗中的內源性靶標極其敏感的數據。基於乾涉的表面等離子共振（SPR）、掃描開爾文奈米探針、原子力顯微鏡等技術用於無標記檢測。此外，作為個性化治療工作流程的一部分，即使安裝每年識別出的數千種潛在診斷生物標記中的少數，也需要臨床高效的生物感測器技術來即時監測患者的多種生物標記。因此，無標記陣列系統非常重要，因此可以支持推動個性化醫療需求的市場成長。

生物醫學系統對無標記陣列系統的需求不斷成長

在生物醫學和生物科學領域，對無標記陣列系統不斷成長的需求得到了高度關注。科學、奈米技術和整合計算配置的進步和更新正在促進無標記陣列系統的發展，例如微陣列、無標記生物感測器陣列等。這些微陣列、無標記生物感測器技術有助於獲得有效的清晰度— —疾病訊號通路、生物標記篩選、藥物發現、蛋白質分析、藥物標靶識別等，因此有助於診斷過程，通過推動市場成長進一步增加市場需求。此外，製造商還致力於開發高效、準確的讀出系統和細胞模型，以啟動細胞和分子水平的機制和功能研究。

藥物輸送效率日益受到關注

基於無標記陣列系統和患者樣本，領先的市場參與者正在生成生物相關數據，這進一步有助於改進藥物開發。無標記方法，例如檢測和測量折射率的局部變化，用於研究不同的相互作用，包括領先的市場參與者正在使用無標記陣列系統和患者樣本生成生物相關數據，這進一步有助於改進藥物開發分子及其受體。例如，質譜被用作一種無標記的藥物輸送方法。例如，默克基質輔助雷射解吸/電離質譜成像(MALDI-MSI) 的科學家們對肽進行了鑑定，以確定其吸收、分佈、代謝和排泄(ADME) 特性，從而隨著利用率的提高而促進了市場成長。藥物輸送實踐。

對原子力光譜的需求不斷成長

原子力顯微鏡 (AFM) 因其先進的應用（包括診斷和癌症研究）而受到很高的需求。此外，AFM 在生理設置中對細胞進行關鍵操作的應用有助於研究活細胞的機械特性。此外，原子力顯微鏡 (AFM) 涉及最少的樣品操作，因此是研究和研究生物材料（例如細菌、DNA、細胞和病毒）原生環境的有效工具。因此，利用 AFM 作為高解析度研究工具來檢查和識別腫瘤細胞的機械特性和超微結構，增強了對無標記陣列系統的市場需求。

可用的客製化

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場。
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球無標籤陣列系統市場展望。

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 按類型（表面等離子體共振、生物層干涉測量、細胞介電光譜等）
    • 按應用（藥物發現、蛋白質界面分析、抗體表徵等）
    • 按最終用戶（製藥和生物技術公司、學術和研究所、契約研究組織等）
    • 按公司分類 (2022)
    • 按地區
  • 產品市場地圖

第 6 章：亞太地區全球無標籤陣列系統市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國 。
    • 印度 。
    • 韓國
    • 日本
    • 澳大利亞

第 7 章：歐洲全球無標籤陣列系統市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：北美腐殖質生物刺激劑市場展望。

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國全球無標籤陣列系統市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 類型
        • 應用
        • 最終用戶
    • 墨西哥全球無標籤陣列系統市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 類型
        • 應用
        • 最終用戶
    • 加拿大全球無標籤陣列系統市場展望
      • 市場規模及預測
        • 按價值
      • 市場佔有率及預測
        • 類型
        • 應用
        • 最終用戶

第 9 章：南美洲全球無標籤陣列系統市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲全球無標籤陣列系統市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 類型
    • 應用
    • 最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非全球無標籤陣列系統
    • 沙烏地阿拉伯全球無標籤陣列系統
    • 阿拉伯聯合大公國全球無標籤陣列系統
    • 科威特全球無標籤陣列系統

第 11 章：市場動態

  • 司機
  • 挑戰

第 12 章：市場趨勢與發展

  • 最近的發展
  • 併購
  • 產品開發

第13章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Merck KGaA
    • Danaher Corporation
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche AG
    • Becton, Dickinson and Company
    • Sartorius AG

第 14 章：戰略建議

簡介目錄
Product Code: 15121

Label-free Array Systems Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as growing demand for personalized medicines, rapid drug delivery, biomarker identification, identification of specific protein markers in specific diseases or conditions, and increased usage of Label-free Array Systems Market as a research tool in drug discovery.

Without the use of fluorescent or radioactive labels, label-free array systems are analytical tools that are utilized to identify and quantify biomolecules in complicated samples. These devices work on the concept of Surface Plasmon Resonance (SPR), which enables the measurement of biomolecule binding to the array surface as well as changes in the reflected light.

Moreover, Label-free array systems are advantageous as there is no need for the use of hazardous or costly labeling agents, which makes them a safer and more affordable substitute compared to conventional labeling techniques. Label-free array devices can be used to analyze biomolecule interactions in real-time without the use of fluorescence or radioactivity, providing dynamic and quantitative data about the interacting molecules.

Increasing Demand for Personalized Medicine

In recent times, modern medicines are gradually moving towards precision medicine to eliminate individual dose dismissal. Label-free array systems eliminate the requirement for dyes, reagents, modified cells, and tags while providing data that is extremely sensitive for an endogenous target in live cell experiments. Techniques such as Interference-based Surface Plasmon Resonance (SPR), Scanning Kelvin Nanoprobe, Atomic Force Microscopy, etc., are utilized in label-free detection. Furthermore, installing even a few of the thousands of potential diagnostic biomarkers identified each year as part of personalized treatment workflows necessitates clinically efficient biosensor technologies to monitor multiple biomarkers in patients in real-time. In this way, the label-free array system is of great importance and is thereby adding to support the market growth driving personalized medicine demand.

Growing Demand for Label-Free Array Systems in Biomedical System

The growing demand for label-free array systems is highly observed in biomedical medicines along with biological sciences. Advancements and update in science, nanotechnology, and integrated computational configuration are promoting the development of label-free array systems such as microarrays, label-free biosensor arrays, etc. These microarray, label-free biosensor techniques are helpful in getting efficient clarity of- disease signaling pathways, biomarker screening, drug discovery, protein profiling, drug target identification, etc., and are therefore aiding the diagnostic process, which is further adding to the market demand by propelling the market growth. Also, Manufacturers are focusing on developing efficient and accurate readout systems and cellular models with respect to launching mechanisms and functional studies on cellular and molecular levels.

Rising Focus on Drug Delivery Efficiency

Based on the Label-Free Array Systems and patient samples, the leading market players are generating biorelevant data, which further helps in improved drug development. The Label-free methods, like detection and measurement of a local change in refractive index, are utilized for studying distinct interactions comprising Leading market players are producing biorelevant data using Label-Free Array Systems and patient samples, which further aids in improved medication development drug molecules and their receptors. For instance, Mass Spectroscopy is utilized as a label-free approach to drug delivery. For Instance, scientists from Merck matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) to peptides to identify their absorption, distribution, metabolism, and excretion (ADME) properties, thereby increasing the market growth with the rise in utilization for drug delivery practices.

Growing demand for Atomic Force Spectroscopy

Atomic Force Microscopy (AFM) is in high demand due to its advanced applications, including diagnosis and carrying cancer research. The applications of AFM to carry crucial operations on cells, moreover, in physiological setups, help in the study of the mechanical characteristics of the living cells. Also, Atomic Force Microscopy (AFM) includes the involvement of minimum sample manipulation and is, therefore, an efficient tool for the research and study of biological materials such as bacteria, DNA, cells, and viruses in their native environments. Hence, the market demand for label-free array systems is enhanced by the utilization of AFM to be employed as a high-resolution research tool to examine and identify the mechanical properties and ultrastructure of tumor cells.

Market Segmentation

Label-free Array Systems Market is segmented based on the type, application, end-user, and region. Based on type, the market is segmented into surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others. Based on application, the market is segmented into drug discovery, protein interface analysis, antibody characterization, and others. Based on end users, the market is further fragmented into pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and others. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Sartorius AG, etc.., are some of the major players operating in the Global Label-free Array Systems Market.

Report Scope

In this report, Global Label-free Array Systems Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Label-free Array Systems Market, By Type:

  • Surface Plasmon Resonance
  • Bio-layer Interferometry
  • Cellular Dielectric Spectroscopy
  • Others

Label-free Array Systems Market, By Mode:

  • Automated ELISA Analyzers
  • Semi-Automated Analyzers

Label-free Array Systems Market, By Application:

  • Drug Discovery
  • Protein Interface Analysis
  • Antibody Characterization
  • Others

Label-free Array Systems Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institute
  • Contract Research Organization
  • Others

Label-free Array Systems Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Label-free Array Systems Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Label-free Array Systems Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (surface plasmon resonance, bio-layer interferometry, cellular dielectric spectroscopy, and others)
    • 5.2.2. By Application (Drug Discovery, Protein Interface Analysis, Antibody Characterization and Others)
    • 5.2.3. By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Contract Research Organization and Others)
    • 5.2.4. By Company (2022)
    • 5.2.5. By Region
  • 5.3. Product Market Map

6. Asia-Pacific Global Label-free Array Systems Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Type
    • 6.2.2. Application
    • 6.2.3. End user
    • 6.2.4. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Global Label-free Array Systems Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Type
        • 6.3.1.2.2. Application
        • 6.3.1.2.3. End user
    • 6.3.2. India Global Label-free Array Systems Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Type
        • 6.3.2.2.2. Application
        • 6.3.2.2.3. End user
    • 6.3.3. South Korea Global Label-free Array Systems Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Type
        • 6.3.3.2.2. Application
        • 6.3.3.2.3. End user
    • 6.3.4. Japan Global Label-free Array Systems Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Type
        • 6.3.4.2.2. Application
        • 6.3.4.2.3. End user
    • 6.3.5. Australia Global Label-free Array Systems Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Type
        • 6.3.5.2.2. Application
        • 6.3.5.2.3. End user

7. Europe Global Label-free Array Systems Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Type
    • 7.2.2. Application
    • 7.2.3. End user
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Global Label-free Array Systems Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Type
        • 7.3.1.2.2. Application
        • 7.3.1.2.3. End user
    • 7.3.2. Germany Global Label-free Array Systems Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Type
        • 7.3.2.2.2. Application
        • 7.3.2.2.3. End user
    • 7.3.3. United Kingdom Global Label-free Array Systems Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Type
        • 7.3.3.2.2. Application
        • 7.3.3.2.3. End user
    • 7.3.4. Italy Global Label-free Array Systems Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Type
        • 7.3.4.2.2. Application
        • 7.3.4.2.3. End user
    • 7.3.5. Spain Global Label-free Array Systems Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Type
        • 7.3.5.2.2. Application
        • 7.3.5.2.3. End user

8. North America Humic-based bio stimulants Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Type
    • 8.2.2. Application
    • 8.2.3. End user
    • 8.2.4. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Global Label-free Array Systems Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Type
        • 8.3.1.2.2. Application
        • 8.3.1.2.3. End user
    • 8.3.2. Mexico Global Label-free Array Systems Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Type
        • 8.3.2.2.2. Application
        • 8.3.2.2.3. End user
    • 8.3.3. Canada Global Label-free Array Systems Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Type
        • 8.3.3.2.2. Application
        • 8.3.3.2.3. End user

9. South America Global Label-free Array Systems Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Type
    • 9.2.2. Application
    • 9.2.3. End user
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Global Label-free Array Systems Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Type
        • 9.3.1.2.2. Application
        • 9.3.1.2.3. End user
    • 9.3.2. Argentina Global Label-free Array Systems Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Type
        • 9.3.2.2.2. Application
        • 9.3.2.2.3. End user
    • 9.3.3. Colombia Global Label-free Array Systems Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Type
        • 9.3.3.2.2. Application
        • 9.3.3.2.3. End user

10. Middle East and Africa Global Label-free Array Systems Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Type
    • 10.2.2. Application
    • 10.2.3. End user
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Global Label-free Array Systems Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Type
        • 10.3.1.2.2. Application
        • 10.3.1.2.3. End user
    • 10.3.2. Saudi Arabia Global Label-free Array Systems Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Type
        • 10.3.2.2.2. Application
        • 10.3.2.2.3. End user
    • 10.3.3. UAE Global Label-free Array Systems Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Type
        • 10.3.3.2.2. Application
        • 10.3.3.2.3. End user
    • 10.3.4. Kuwait Global Label-free Array Systems Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Type
        • 10.3.4.2.2. Application
        • 10.3.4.2.3. End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. Illumina, Inc.
    • 13.6.2. Thermo Fisher Scientific, Inc.
    • 13.6.3. Agilent Technologies, Inc.
    • 13.6.4. PerkinElmer, Inc.
    • 13.6.5. Merck KGaA
    • 13.6.6. Danaher Corporation
    • 13.6.7. Bio-Rad Laboratories, Inc.
    • 13.6.8. F. Hoffmann-La Roche AG
    • 13.6.9. Becton, Dickinson and Company
    • 13.6.10. Sartorius AG

14. Strategic Recommendations